This is a demo store. No orders will be fulfilled.

首页   400-620-6333
  • 登录
  • 注册
  • 英文站
切换导航
我的购物车
搜索
高级搜索
菜单
登录
设置
྾

2-乙氧基苯甲酰胺

COA COA
    级别和纯度:
  • ≥98%(GC)
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
E156355-1g
 1g 期货 Stock Image
E156355-5g
 5g 期货 Stock Image
E156355-25g
 25g 现货 Stock Image
大包装询价 收藏夹 比较  SDS下载  DATASHEET  质量标准
查看相关系列
Epigenetic Reader Domain (784) 羰基化合物 (2389) 酰胺 (351)
main product photo

基本描述

别名 乙基水杨胺 | 乙柳酰胺 | 邻乙氧基苯甲酰胺 | 乙水杨胺
英文别名 ethenzamide | Etenzamide [DCIT] | KS-5320 | STK105005 | D01466 | SR-01000877236 | Ethenzamide [INN:BAN:JAN] | MFCD00007977 | UNII-L929ZCK4BF | DB13544 | Ethenzamidum | FT-0612206 | ETHENZAMIDE [WHO-DD] | ETHENZAMIDE [JAN] | Q-201075 | Katagrippe | WLN: ZV
规格或纯度 ≥98%(GC)
英文名称 2-Ethoxybenzamide
储存温度 避光,-20°C储存
运输条件 超低温冰袋运输
产品介绍


Anovigam is white or almost-white crystalline powder. Almost odorless. Tasteless. It is widely used as an antipyretic anodyne.

纯度 ≥98%(GC)

关联靶点（人）

F2 Tclin Thrombin (11687 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PGR Tclin Progesterone receptor (8562 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
AR Tclin Androgen Receptor (11781 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
KCNH2 Tclin HERG (29587 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
TBXA2R Tclin Thromboxane A2 receptor (5717 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
THRB Tclin Thyroid hormone receptor beta-1 (7926 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PDE4A Tclin Phosphodiesterase 4A (1943 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
HRH3 Tclin Histamine H3 receptor (10389 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
TARDBP Tchem TAR DNA-binding protein 43 (40113 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID

关联靶点（其它种属）

Hdac6 Histone deacetylase 6 (222 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
lef Anthrax lethal factor (7585 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
rep Replicase polyprotein 1ab (378 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
SARS-CoV-2 (38078 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

名称和识别符

PubChem SID 504750651
分子类型 小分子
IIUPAC Name 2-ethoxybenzamide
INCHI 1S/C9H11NO2/c1-2-12-8-6-4-3-5-7(8)9(10)11/h3-6H,2H2,1H3,(H2,10,11)
InChi Key SBNKFTQSBPKMBZ-UHFFFAOYSA-N
Smiles CCOC1=CC=CC=C1C(=O)N
Isomeric SMILES CCOC1=CC=CC=C1C(=O)N
分子量 165.19
Beilstein号 10,93
Reaxy-Rn 2208582
Reaxys-RN link address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=2208582&ln=

化学和物理性质

溶解性 Solubility in Methanol almost transparency;
敏感性 对光敏感
熔点 130-134℃
分子量 165.190 g/mol
XLogP3 1.200
氢键供体数Hydrogen Bond Donor Count 1
氢键受体数Hydrogen Bond Acceptor Count 2
可旋转键计数Rotatable Bond Count 3
精确质量Exact Mass 165.079 Da
单同位素质量Monoisotopic Mass 165.079 Da
拓扑极表面积Topological Polar Surface Area 52.300 Ų
重原子数Heavy Atom Count 12
形式电荷Formal Charge 0
复杂度Complexity 159.000
同位素原子数Isotope Atom Count 0
定义的原子立体中心计数Defined Atom Stereocenter Count 0
未定义的原子立体中心计数Undefined Atom Stereocenter Count 0
定义的键立体中心计数Defined Bond Stereocenter Count 0
未定义的键立体中心计数Undefined Bond Stereocenter Count 0
所有立体化学键的总数The total count of all stereochemical bonds 0
共价键合单元计数Covalently-Bonded Unit Count 1

安全和危险性（GHS）

WGK Germany 2
RTECS CV4900000
Merck Index 3731
个人防护装备 Eyeshields， Gloves， type N95 (US)， type P1 (EN143) respirator filter

质检证书（CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！

找到5个结果

批号(Lot Number) 证书类型 货号
J2515631 分析证书 E156355
H2318520 分析证书 E156355
H2318521 分析证书 E156355
H2318522 分析证书 E156355
H2318523 分析证书 E156355

可替换产品

  1. 2-乙氧基苯甲酰胺
    2-乙氧基苯甲酰胺
    • 10mM in DMSO

    ¥439.90

引用文献

1. P H Tan,A K Chou,J S Perng.  (1997-08-01)  Accidental shock during epidural anesthesia in a patient with NSAID-induced hyporeninemic hypoaldosteronism..  Journal of clinical anesthesia,  9  ((5)): (424-427).  [PMID:9257212]
2. H Uehara,H Otsuka,K Izumi.  (1999-03-17)  Modifying effects of a mixture of acetaminophen, aspirin, dipyrone and ethenzamide on a multiorgan initiation model and its carcinogenicity in male F344 rats..  Cancer letters,  135  ((1)): (83-90).  [PMID:10077225]
3. N Hirasawa,H Okamoto,K Danjo.  (1999-04-23)  Lactose as a low molecular weight carrier of solid dispersions for carbamazepine and ethenzamide..  Chemical & pharmaceutical bulletin,  47  ((3)): (417-420).  [PMID:10212391]
4. S Aoki,T Mizutani,K Danjo.  (2000-03-08)  Studies on the number of contacts between ibuprofen and ethenzamide using thermal analysis..  Chemical & pharmaceutical bulletin,  48  ((1)): (140-141).  [PMID:10705490]
5. T Kawaguchi,H Sunada,Y Yonezawa,K Danjo,M Hasegawa,T Makino,H Sakamoto,K Fujita,T Tanino,H Kokubo.  (2000-05-16)  Granulation of acetaminophen by a rotating fluidized-bed granulator..  Pharmaceutical development and technology,  5  ((2)): (141-151).  [PMID:10810744]
6. Kunikazu Moribe,Masami Tsuchiya,Yuichi Tozuka,Kentaro Yamaguchi,Toshio Oguchi,Keiji Yamamoto.  (2004-05-11)  Grinding-induced equimolar complex formation between thiourea and ethenzamide..  Chemical & pharmaceutical bulletin,  52  ((5)): (524-529).  [PMID:15133201]
7. Tadashi Fukunaka,Kohta Sawaguchi,Boris Golman,Kunio Shinohara.  (2005-03-29)  Effect of particle shape of active pharmaceutical ingredients prepared by fluidized-bed jet-milling on cohesiveness..  Journal of pharmaceutical sciences,  94  ((5)): (1004-1012).  [PMID:15793798]
8. Tadashi Fukunaka,Kohta Sawaguchi,Boris Golman,Kunio Shinohara.  (2005-12-06)  Variation in particle shape of active pharmaceutical ingredients prepared by fluidized-bed jet-milling..  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,  125  ((12)): (951-957).  [PMID:16327240]
9. Jinichi Fukami,Etsuo Yonemochi,Yasuo Yoshihashi,Katsuhide Terada.  (2006-01-26)  Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose..  International journal of pharmaceutics,  310  ((1-2)): (101-109).  [PMID:16434157]
10. Takuto Mizoe,Shuji Beppu,Tetsuya Ozeki,Hiroaki Okada.  (2007-06-22)  One-step preparation of drug-containing microparticles to enhance the dissolution and absorption of poorly water-soluble drugs using a 4-fluid nozzle spray drier..  Journal of controlled release : official journal of the Controlled Release Society,  120  ((3)): (205-210).  [PMID:17582644]
11. Y Fujimaki,T Matsubara,T Sakamoto,D Sasakura,T Miura,M Takekawa,Y Hiyama.  (2009-06-18)  Distribution of ethenzamide and other ingredients on granule surfaces studied by Raman microspectroscopy and mapping..  Die Pharmazie,  64  ((5)): (316-322).  [PMID:19530442]
12. Silvina Pagola,Peter W Stephens.  (2009-11-07)  Herringbone array of hydrogen-bonded ribbons in 2-ethoxybenzamide from high-resolution X-ray powder diffraction..  Acta crystallographica. Section C, Crystal structure communications,  65  ((Pt 11)): (o583-o586).  [PMID:19893241]
13. Yusuke Nishiyama,Michael H Frey,Sseziwa Mukasa,Hiroaki Utsumi.  (2009-11-11)  (13)C Solid-state NMR chromatography by magic angle spinning (1)H T(1) relaxation ordered spectroscopy..  Journal of magnetic resonance (San Diego, Calif. : 1997),  202  ((2)): (135-139).  [PMID:19900827]
14. Tatsuo Koide,Takuya Nagato,Yoshiyuki Kanou,Kou Matsui,Susumu Natsuyama,Toru Kawanishi,Yukio Hiyama.  (2012-12-19)  Detection of component segregation in granules manufactured by high shear granulation with over-granulation conditions using near-infrared chemical imaging..  International journal of pharmaceutics,  441  ((1-2)): (135-145).  [PMID:23247019]
15. Rumi Tanoue,Kei Nomiyama,Haruna Nakamura,Terutake Hayashi,Joon-Woo Kim,Tomohiko Isobe,Ryota Shinohara,Shinsuke Tanabe.  (2014-06-25)  Simultaneous determination of polar pharmaceuticals and personal care products in biological organs and tissues..  Journal of chromatography. A,  1355  (193-205).  [PMID:24958034]
16. Nam Sook Kim,Jihee Kim,Na Young Lim,Ji Hyun Lee,Seongsoo Park,Hoil Kang.  (2019-12-10)  Simultaneous determination of illegal drug substances in dietary supplements for gout and osteoporosis using ultra-performance liquid chromatography and liquid chromatography-quadrupole-time-of-flight mass spectrometry..  Journal of pharmaceutical and biomedical analysis,  179  (113003-113003).  [PMID:31816474]
17. Nam Sook Kim,Sun Hee Moon,Hwan Seong Choi,Ji Hyun Lee,Seongsoo Park,Hoil Kang.  (2020-04-17)  Simultaneous separation and determination of 20 potential adulterant antigout and antiosteoporosis pharmaceutical compounds in herbal food products using LC with electrospray ionization MS/MS and LC with quadrupole-time-of-flight MS..  Journal of separation science,  43  ((14)): (2750-2765).  [PMID:32297430]
18. A Kawada,M Hiruma,H Noguchi,A Akagi,A Ishibashi,J Marshall.  (1996-05-01)  Fixed drug eruption induced by ethenzamide..  Contact dermatitis,  34  ((5)): (369-370).  [PMID:8807239]
19. Y Miyamoto,A Ryu,S Sugawara,M Miyajima,M Matsui,K Takayama,T Nagai.  (1998-10-17)  Optimization of the granulation process for designing tablets..  Chemical & pharmaceutical bulletin,  46  ((9)): (1432-1437).  [PMID:9775438]
20. Y Miyamoto,A Ryu,S Sugawara,M Miyajima,S Ogawa,M Matsui,K Takayama,T Nagai.  (1999-01-07)  Simultaneous optimization of wet granulation process involving factor of drug content dependency on granule size..  Drug development and industrial pharmacy,  24  ((11)): (1055-1065).  [PMID:9876560]
21. H Sunada,M Hasegawa,T Makino,H Sakamoto,K Fujita,T Tanino,H Kokubo,T Kawaguchi.  (1999-01-07)  Study of standard tablet formulation based on fluidized-bed granulation..  Drug development and industrial pharmacy,  24  ((3)): (225-233).  [PMID:9876579]
22. K Nakamura,Y Ogino,R Kitamura,Y Matsuoka,S Kusunose.  (2000-09-22)  [Perioperative management of a patient with a history of over-the-counter analgesic abuse for 20 years]..  Masui. The Japanese journal of anesthesiology,  49  ((8)): (906-908).  [PMID:10998890]
23. Masatoshi Ozawa,Koji Hasegawa,Yorinobu Yonezawa,Hisakazu Sunada.  (2002-06-05)  Preparation of solid dispersion for ethenzamide-carbopol and theophylline-carbopol systems using a twin screw extruder..  Chemical & pharmaceutical bulletin,  50  ((6)): (802-807).  [PMID:12045335]
24.  (2003-04-12)  Cutaneous drug reaction case reports: from the world literature..  American journal of clinical dermatology,  4  ((5)): (365-370).  [PMID:12688840]
25. T Fukunaka,B Golman,K Shinohara.  (2006-03-25)  Continuous grinding kinetics of ethenzamide particles by fluidized-bed jet-milling..  Drug development and industrial pharmacy,  32  ((3)): (347-355).  [PMID:16556539]
26. Keisuke Kuroda,Michio Murakami,Kumiko Oguma,Yuki Muramatsu,Hideshige Takada,Satoshi Takizawa.  (2011-12-24)  Assessment of groundwater pollution in Tokyo using PPCPs as sewage markers..  Environmental science & technology,  46  ((3)): (1455-1464).  [PMID:22191375]
27. Yoshihiro Hayashi,Takahiro Tsuji,Kaede Shirotori,Takuya Oishi,Atsushi Kosugi,Shungo Kumada,Daijiro Hirai,Kozo Takayama,Yoshinori Onuki.  (2017-09-02)  Relationships between response surfaces for tablet characteristics of placebo and API-containing tablets manufactured by direct compression method..  International journal of pharmaceutics,  532  ((1)): (82-89).  [PMID:28859939]
28. Yung-Tai Hsu,Chie-Shaan Su.  (2020-01-18)  Application of Box-Behnken Design to Investigate the Effect of Process Parameters on the Microparticle Production of Ethenzamide through the Rapid Expansion of the Supercritical Solutions Process..  Pharmaceutics,  12  ((1)): [PMID:31947846]
29. Yoshihiro Hayashi,Kaede Shirotori,Atsushi Kosugi,Shungo Kumada,Kok Hoong Leong,Kotaro Okada,Yoshinori Onuki.  (2020-07-02)  A Precise Prediction Method for the Properties of API-Containing Tablets Based on Data from Placebo Tablets..  Pharmaceutics,  12  ((7)): [PMID:32605318]

溶液计算器

上海阿拉丁生化科技股份有限公司
© 2016 ALADDIN-E.COM . 版权所有,未经授权禁止拷贝本站资料,如有违反,将追究法律责任

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。

上海工商 危险品化学品经营许可证（带存储）营业执照(三证合一)